Table 1.

Criteria for Selecting Patients for the Current Study

Eligibility Criteria
Inclusion criteria
(1) Women ≥22 years old
(2) Women who underwent primary or revision augmentation mammaplasty using silicone gel–filled breast implants for esthetic purposes
(3) Women with an adequate amount of tissue for coverage of the breast implant
(4) Women with availability of follow-up data
Exclusion criteria
(1) Women with unilateral or bilateral presence of premalignant breast lesions
(2) Women with breast cancer genes 1 or 2 (BRCA1 or BRCA2) mutations with no history of taking bilateral mastectomy
(3) Women with untreated malignancies
(4) Women with an inadequate amount of or inappropriate tissue for coverage of the breast implant because of radiation-induced damage, vascular compromise, or impaired wound healing
(5) Women with abscess or infection
(6) Women who had a history of taking any drugs that may interfere with blood clotting or raise risks of developing postoperative complications
(7) Women with underlying medical conditions that may raise risks for developing postoperative complications [eg, obesity (BMI ≥40), diabetes mellitus, autoimmune disease, chronic lung, severe cardiovascular disease connective tissue, or rheumatoid disease)
(8) Women who are pregnant or breastfeeding
(9) Women with medical conditions that may interfere with wound healing (eg, active infectious collagen disease)
(10) Women with active fever (temperature >38°C)
(11) Women with severe lung disease (eg, chronic obstructive pulmonary disease)
(12) Women with cystic fibrosis
(13) Women with active cutaneous or systemic infections
(14) Women undergoing radiotherapy or chemotherapy within 6 mo preoperatively
(15) Women lost to follow-up
(16) Women who are deemed to be ineligible for the current analysis according to our judgment

BMI, body mass index.